Vaccine
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Did the COVID-19 experience change U.S. parents' attitudes towards HPV vaccination? Results from a national survey..
42:1704-1713.
2024
-
Assessing parental intention to vaccinate against COVID-19, influenza, and RSV in the United States in late 2023..
41:7503-7514.
2023
-
Assessing vaccine hesitancy and support for vaccination requirements for pets and potential Spillovers from humans..
41:7322-7332.
2023
-
U.S. public support and opposition to vaccination mandates in K-12 education in light of the COVID-19 pandemic..
41:7103-7115.
2023
-
Imperfect messengers? An analysis of vaccine confidence among primary care physicians..
40:2588-2603.
2022
-
Joining the herd? U.S. public opinion and vaccination requirements across educational settings during the COVID-19 pandemic..
39:2375-2385.
2021
-
Evaluation of the safety profile of the vaccine candidate Brucella melitensis 16MvjbR strain in goats..
39:617-625.
2021
-
Vaccination against coronaviruses in domestic animals..
38:5123-5130.
2020
-
Global assessment of national mandatory vaccination policies and consequences of non-compliance..
38:7865-7873.
2020
-
Neutralizing antibodies to gB based CMV vaccine requires full length antigen but reduced virus neutralization on non-fibroblast cells limits vaccine efficacy in the guinea pig model..
38:2340-2349.
2020
-
Protection against bovine respiratory syncytial virus in calves vaccinated with adjuvanted modified live vaccine administered in the face of maternal antibody..
38:298-308.
2020
-
PNAG-specific equine IgG1 mediates significantly greater opsonization and killing of Prescottella equi (formerly Rhodococcus equi) than does IgG4/7..
37:1142-1150.
2019
-
Enhanced protective efficacy of Borrelia burgdorferi BB0172 derived-peptide based vaccine to control Lyme disease..
37:5596-5606.
2019
-
Development of a synthetic Vi polysaccharide vaccine for typhoid fever..
35:7121-7126.
2017
-
Development of a novel dual-domain nanoparticle antigen construct for universal influenza vaccine..
35:7026-7032.
2017
-
Antibody titers to vaccination are not predictive of level of protection against a BVDV type 1b challenge in Bos indicus - Bos taurus steers..
34:5053-5059.
2016
-
Infectivity of attenuated poxvirus vaccine vectors and immunogenicity of a raccoonpox vectored rabies vaccine in the Brazilian Free-tailed bat (Tadarida brasiliensis)..
34:5352-5358.
2016
-
Oral delivery of wafers made from HBsAg-expressing maize germ induces long-term immunological systemic and mucosal responses..
33:2881-2886.
2015
-
Altered host immune responses to membrane vesicles from Salmonella and Gram-negative pathogens..
33:5012-5019.
2015
-
Glycoprotein B (gB) vaccines adjuvanted with AS01 or AS02 protect female guinea pigs against cytomegalovirus (CMV) viremia and offspring mortality in a CMV-challenge model..
32:2756-2762.
2014
-
Supercritical fluid extraction provides an enhancement to the immune response for orally-delivered hepatitis B surface antigen..
32:1240-1246.
2014
-
Immunotherapeutics to prevent the replication of Brucella in a treatment failure mouse model..
32:918-923.
2014
-
New attenuated vaccine against columnaris disease in fish: choosing the right parental strain is critical for vaccine efficacy..
31:5276-5280.
2013
-
Dengue dynamics and vaccine cost-effectiveness in Brazil..
31:3957-3961.
2013
-
Optimal targeting of seasonal influenza vaccination toward younger ages is robust to parameter uncertainty..
31:3079-3089.
2013
-
Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheep..
31:559-565.
2013
-
Immunogenicity of a recombinant Rift Valley fever MP-12-NSm deletion vaccine candidate in calves..
31:4988-4994.
2013
-
Bioencapsulation of the hepatitis B surface antigen and its use as an effective oral immunogen..
30:2937-2942.
2012
-
Cell culture attenuation eliminates rMd5Meq-induced bursal and thymic atrophy and renders the mutant virus as an effective and safe vaccine against Marek's disease..
30:5151-5158.
2012
-
Measuring bovine viral diarrhea virus vaccine response: using a commercially available ELISA as a surrogate for serum neutralization assays..
30:6559-6563.
2012
-
Enhancing the role of veterinary vaccines reducing zoonotic diseases of humans: linking systems biology with vaccine development..
29:7197-7206.
2011
-
Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine..
29:5221-5231.
2011
-
Development of DIVA (differentiation of infected from vaccinated animals) vaccines utilizing heterologous NA and NS1 protein strategies for the control of triple reassortant H3N2 influenza in turkeys..
29:7966-7974.
2011
-
Immunization of mice with gamma-irradiated Brucella neotomae and its recombinant strains induces protection against virulent B. abortus, B. melitensis, and B. suis challenge..
29:784-794.
2011
-
Characterization and evaluation of avian influenza NS1 mutant virus as a potential live and killed DIVA (differentiating between infected and vaccinated animals) vaccine for chickens..
28:2388-2396.
2010
-
Comparative evaluation of vaccine efficacy of recombinant Marek's disease virus vaccine lacking Meq oncogene in commercial chickens..
28:1294-1299.
2010
-
Brucellosis: the case for live, attenuated vaccines..
27 Suppl 4:D40-D43.
2009
-
A live guinea pig cytomegalovirus vaccine deleted of three putative immune evasion genes is highly attenuated but remains immunogenic in a vaccine/challenge model of congenital cytomegalovirus infection..
27:4209-4218.
2009
-
Basal and stimulus-induced cytokine expression is selectively impaired in peripheral blood mononuclear cells of newborn foals..
27:674-683.
2009
-
Recombinant Marek's disease virus (MDV) lacking the Meq oncogene confers protection against challenge with a very virulent plus strain of MDV..
26:1887-1892.
2008
-
Evaluation of novel Brucella melitensis unmarked deletion mutants for safety and efficacy in the goat model of brucellosis..
24:5169-5177.
2006
-
Protection against congenital cytomegalovirus (CMV) disease, conferred by a replication-disabled, bacterial artificial chromosome (BAC)-based DNA vaccine..
24:6175-6186.
2006
-
Multicomponent Lyme vaccine: three is not a crowd..
23:3687-3696.
2005
-
A serine proteinase inhibitor (serpin) from ixodid tick Haemaphysalis longicornis; cloning and preliminary assessment of its suitability as a candidate for a tick vaccine..
21:2844-2851.
2003
-
Plant-based vaccines: unique advantages..
19:2742-2748.
2001
-
cDNA cloning, characterization and vaccine effect analysis of Haemaphysalis longicornis tick saliva proteins..
19:4287-4296.
2001
-
Absence of shedding of two B. abortus strains in goats after vaccination with live vaccines..
18:3018-3020.
2000
-
Mitogenic synthetic polynucleotides suppress the antibody response to a bacterial polysaccharide..
16:76-82.
1998
-
Antigen dependent adjuvant activity of a polydispersed beta-(1,4)-linked acetylated mannan (acemannan)..
10:551-557.
1992
Identity
International Standard Serial Number (ISSN)